Review




Structured Review

CH Instruments chi-square p-value
Chi Square P Value, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chi-squared+p-value/chi+square+p+value/pm40625921-119-12-12
Average 90 stars, based on 1 article reviews
chi-square p-value - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Significance Assay:

Article Title: Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.
Article Snippet: Background: The liver is the most frequent site of metastases in colorectal cancer (CRC).. This study aimed to assess the response rate and survival outcomes in metastatic CRC patients with non-liver metastases (NLM) compared to those with liver metastases (LM) across different lines of treatment.. Methods: A total of 17,924 mCRC patients included in 26 trials from the ARCAD CRC database were analyzed.

Article Title: Survey on diagnosis and treatment of cognitive impairment in Sichuan area in China.
Article Snippet: Symptoms are present/recorded (%) Characteristic AD (n= 1121, 78.34%) VD (n= 114, 7.97%) Chi-squared p-value Memory impairments 853/922 (92.52%) 64/73 (87.67%) 2.198 0.138 Language impairments 334/876 (38.13%) 38/76 (50%) 4.140 0.042 Visuospatial dysfunction 297/834 (35.61%) 17/65 (26.15%) 2.373 0.123 Executive function impairments 368/828 (44.44%) 26/65 (40%) 0.483 0.487 Arithmetic difficulty 497/833 (59.66%) 44/64 (68.75%) 2.050 0.152 Behavioral symptoms 316/850 (37.18%) 24/81 (29.63%) 1.817 0.178 Emotional symptom 343/840 (40.83%) 16/79 (20.25%) 12.848 0.000 Abbreviations: AD, Alzheimer’s disease; VD, vascular dementia.

Article Title: Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patterns.
Article Snippet: Next, we split end-motifs into those that occur at frequencies above and below the expected random frequency (1/ 256=0.0039) inTP53-wildtype.Within TP53m-carriers,we observed an increased frequency in 63.0% (63/100) and a decreased frequency in 67.3% (105/156) of motifs that occur above and below the expected frequency (Chi-squared p-value < 0.001) compared to TP53-wildtype (Supplementary Fig. 9A).

Article Title: Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patterns
Article Snippet: Within TP53m -carriers, we observed an increased frequency in 63.0% (63/100) and a decreased frequency in 67.3% (105/156) of motifs that occur above and below the expected frequency (Chi-squared p-value < 0.001) compared to TP53 -wildtype (Supplementary Fig. ).

Article Title: Genetic analysis and functional assessment of a TGFBR2 variant in micrognathia and cleft palate.
Article Snippet: To test if homozygotes have a phenotype, we intercrossed heterozygotes and saw no deviation from expected ratios of Tgfbr2V387M/wt heterozygotes or Tgfbr2V387M/V387M homozygotes from 66 weaned animals (Chi-squared p-value = 0.716; Fig 2e, Table 1).

Article Title: Italian Technostress Creators Scale: validation of an assessment tool
Article Snippet: AC CE PT ED AC CE PT ED Fit indices Acceptable Rate Root mean square error of approximation (RMSEA) <0.08 Standardized Root Mean Square Residual (SRMR) <0.08 Comparative fit index (CFI) >0.9 Tucker-Lewis Index (TLI) (=Non-Normed Fit Index NNFI) >0.9 Minimum discrepancy function by degrees of freedom divided (CMIN/DF) <5 (Chi-squared P-value) χ2 P-value >0.05 AC CE PT ED N of participants Mean (± SD) Age 90 37.4 (± 10.9) N of participants Percentage Gender Male 42 46.7% Female 48 53.3% Marital status Unmarried 42 46.7% Married/cohabiting 48 53.3% Children None 62 68.9% One 12 13.3% More than one 16 17.8% Education High school diploma 12 13.3% College degree 64 71.1% Post-gradual degree 14 15.6% Job Highly specialized profession 58 64.4% Technical profession 4 4.4% Service industry 11 12.2% Office workers 13 14.4% Managers, entrepreneurs, legislators 2 2.2% Other 2 2.2% Work location On site only 32 35.6% On site most of the time 38 42.2% Half remotely and half on site 13 14.4% Remotely most of the time 7 7.8% Technology use at work Every day 86 95.6% At least 3 days per week 2 2.2% At least 1 day per week 2 2.2% Technology training course Never participated 31 34.4% Participated privately 21 23.3% Participated through company 38 42.2% AC CE PT ED Cronbach’s α and McDonald’s ω for each item are calculated as if the item if left out (leave-oneout analysis) Mean Standard deviation Inter-item correlation Cronbach’s α McDonald’s ω TCS 3.59 0.517 - 0.881 0.887 Q1 3.44 1.237 0.584 0.873 0.880 Q2 3.51 1.192 0.567 0.874 0.880 Q3 3.48 1.124 0.607 0.873 0.879 Q4 3.61 1.148 0.647 0.871 0.878 Q5 3.48 1.238 0.337 0.880 0.885 Q6 4.03 1.065 0.536 0.875 0.881 Q7 2.91 1.269 0.452 0.877 0.883 Q8 3.72 0.912 0.592 0.874 0.879 Q9 3.88 0.872 0.610 0.874 0.879 Q10 3.32 1.037 0.482 0.876 0.882 Q11 3.57 0.995 0.452 0.877 0.883 Q12 3.87 0.864 0.560 0.875 0.880 Q13 4.07 0.981 0.461 0.877 0.883 Q14 3.91 0.932 0.577 0.874 0.879 Q15 4.03 1.075 0.575 0.874 0.880 Q16 4.26 0.966 0.459 0.877 0.882 Q17 3.00 0.994 0.423 0.877 0.884 Q18 3.26 0.931 0.480 0.876 0.882 Q19 3.57 0.972 0.474 0.876 0.882 Q20 3.57 0.984 0.439 0.877 0.883 Q21 3.33 1.071 0.243 0.882 0.888 Q22 2.62 1.118 0.180 0.884 0.889 Q23 3.51 1.104 0.386 0.878 0.884 Q24 3.20 1.163 0.335 0.880 0.886 Q25a 3.81 0.982 0.138 0.884 0.889 Q26a 4.28 0.862 0.132 0.883 0.889 Q27a 3.69 0.956 0.101 0.884 0.890 a item is on an inverted scale; these three items are questions regarding interest in technology added to the backtranslated scale.

Standard Deviation:

Article Title: Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.
Article Snippet: Background: The liver is the most frequent site of metastases in colorectal cancer (CRC).. This study aimed to assess the response rate and survival outcomes in metastatic CRC patients with non-liver metastases (NLM) compared to those with liver metastases (LM) across different lines of treatment.. Methods: A total of 17,924 mCRC patients included in 26 trials from the ARCAD CRC database were analyzed.

Article Title: Survey on diagnosis and treatment of cognitive impairment in Sichuan area in China.
Article Snippet: Symptoms are present/recorded (%) Characteristic AD (n= 1121, 78.34%) VD (n= 114, 7.97%) Chi-squared p-value Memory impairments 853/922 (92.52%) 64/73 (87.67%) 2.198 0.138 Language impairments 334/876 (38.13%) 38/76 (50%) 4.140 0.042 Visuospatial dysfunction 297/834 (35.61%) 17/65 (26.15%) 2.373 0.123 Executive function impairments 368/828 (44.44%) 26/65 (40%) 0.483 0.487 Arithmetic difficulty 497/833 (59.66%) 44/64 (68.75%) 2.050 0.152 Behavioral symptoms 316/850 (37.18%) 24/81 (29.63%) 1.817 0.178 Emotional symptom 343/840 (40.83%) 16/79 (20.25%) 12.848 0.000 Abbreviations: AD, Alzheimer’s disease; VD, vascular dementia.

Article Title: Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patterns.
Article Snippet: Next, we split end-motifs into those that occur at frequencies above and below the expected random frequency (1/ 256=0.0039) inTP53-wildtype.Within TP53m-carriers,we observed an increased frequency in 63.0% (63/100) and a decreased frequency in 67.3% (105/156) of motifs that occur above and below the expected frequency (Chi-squared p-value < 0.001) compared to TP53-wildtype (Supplementary Fig. 9A).

Article Title: Cell-free DNA from germline TP53 mutation carriers reflect cancer-like fragmentation patterns
Article Snippet: Within TP53m -carriers, we observed an increased frequency in 63.0% (63/100) and a decreased frequency in 67.3% (105/156) of motifs that occur above and below the expected frequency (Chi-squared p-value < 0.001) compared to TP53 -wildtype (Supplementary Fig. ).

Article Title: Genetic analysis and functional assessment of a TGFBR2 variant in micrognathia and cleft palate.
Article Snippet: To test if homozygotes have a phenotype, we intercrossed heterozygotes and saw no deviation from expected ratios of Tgfbr2V387M/wt heterozygotes or Tgfbr2V387M/V387M homozygotes from 66 weaned animals (Chi-squared p-value = 0.716; Fig 2e, Table 1).

Article Title: Italian Technostress Creators Scale: validation of an assessment tool
Article Snippet: AC CE PT ED AC CE PT ED Fit indices Acceptable Rate Root mean square error of approximation (RMSEA) <0.08 Standardized Root Mean Square Residual (SRMR) <0.08 Comparative fit index (CFI) >0.9 Tucker-Lewis Index (TLI) (=Non-Normed Fit Index NNFI) >0.9 Minimum discrepancy function by degrees of freedom divided (CMIN/DF) <5 (Chi-squared P-value) χ2 P-value >0.05 AC CE PT ED N of participants Mean (± SD) Age 90 37.4 (± 10.9) N of participants Percentage Gender Male 42 46.7% Female 48 53.3% Marital status Unmarried 42 46.7% Married/cohabiting 48 53.3% Children None 62 68.9% One 12 13.3% More than one 16 17.8% Education High school diploma 12 13.3% College degree 64 71.1% Post-gradual degree 14 15.6% Job Highly specialized profession 58 64.4% Technical profession 4 4.4% Service industry 11 12.2% Office workers 13 14.4% Managers, entrepreneurs, legislators 2 2.2% Other 2 2.2% Work location On site only 32 35.6% On site most of the time 38 42.2% Half remotely and half on site 13 14.4% Remotely most of the time 7 7.8% Technology use at work Every day 86 95.6% At least 3 days per week 2 2.2% At least 1 day per week 2 2.2% Technology training course Never participated 31 34.4% Participated privately 21 23.3% Participated through company 38 42.2% AC CE PT ED Cronbach’s α and McDonald’s ω for each item are calculated as if the item if left out (leave-oneout analysis) Mean Standard deviation Inter-item correlation Cronbach’s α McDonald’s ω TCS 3.59 0.517 - 0.881 0.887 Q1 3.44 1.237 0.584 0.873 0.880 Q2 3.51 1.192 0.567 0.874 0.880 Q3 3.48 1.124 0.607 0.873 0.879 Q4 3.61 1.148 0.647 0.871 0.878 Q5 3.48 1.238 0.337 0.880 0.885 Q6 4.03 1.065 0.536 0.875 0.881 Q7 2.91 1.269 0.452 0.877 0.883 Q8 3.72 0.912 0.592 0.874 0.879 Q9 3.88 0.872 0.610 0.874 0.879 Q10 3.32 1.037 0.482 0.876 0.882 Q11 3.57 0.995 0.452 0.877 0.883 Q12 3.87 0.864 0.560 0.875 0.880 Q13 4.07 0.981 0.461 0.877 0.883 Q14 3.91 0.932 0.577 0.874 0.879 Q15 4.03 1.075 0.575 0.874 0.880 Q16 4.26 0.966 0.459 0.877 0.882 Q17 3.00 0.994 0.423 0.877 0.884 Q18 3.26 0.931 0.480 0.876 0.882 Q19 3.57 0.972 0.474 0.876 0.882 Q20 3.57 0.984 0.439 0.877 0.883 Q21 3.33 1.071 0.243 0.882 0.888 Q22 2.62 1.118 0.180 0.884 0.889 Q23 3.51 1.104 0.386 0.878 0.884 Q24 3.20 1.163 0.335 0.880 0.886 Q25a 3.81 0.982 0.138 0.884 0.889 Q26a 4.28 0.862 0.132 0.883 0.889 Q27a 3.69 0.956 0.101 0.884 0.890 a item is on an inverted scale; these three items are questions regarding interest in technology added to the backtranslated scale.



Similar Products

90
CH Instruments chi-square p-value
Chi Square P Value, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chi-squared+p-value/chi+square+p+value/pm40625921-119-12-12
Average 90 stars, based on 1 article reviews
chi-square p-value - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Statistik Georg Ferber hasil uji overdispersi model regresi poisson statistik nilai estimasi rasio dispersi 33 836 chi squared 270 692 p value
Hasil Uji Overdispersi Model Regresi Poisson Statistik Nilai Estimasi Rasio Dispersi 33 836 Chi Squared 270 692 P Value, supplied by Statistik Georg Ferber, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chi-squared+p-value/dan+data+deskriptif+eksperimen+gain+jumlah+kontrol+kontrol+konvensional+n+statistik/10__14710_slash_jil__23__4__1085___1092-115-0-6
Average 86 stars, based on 1 article reviews
hasil uji overdispersi model regresi poisson statistik nilai estimasi rasio dispersi 33 836 chi squared 270 692 p value - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
CH Instruments chi-squared p-value
Chi Squared P Value, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chi-squared+p-value/chi+square+p+value/pm40489498-57-26-27
Average 90 stars, based on 1 article reviews
chi-squared p-value - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CH Instruments pearson chi-square p-value
Pearson Chi Square P Value, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chi-squared+p-value/pearson+chi+square+value/pm40211027-110-24-26
Average 90 stars, based on 1 article reviews
pearson chi-square p-value - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd chi-square test and p value using medcalc- 22.030
Chi Square Test And P Value Using Medcalc 22.030, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chi-squared+p-value/chi+square+test+and+p+value+using+medcalc++22+030/pm40214828-37-14-14
Average 90 stars, based on 1 article reviews
chi-square test and p value using medcalc- 22.030 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
CH Instruments hosmer–lemeshow test chi-squared and p value
Hosmer–Lemeshow Test Chi Squared And P Value, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chi-squared+p-value/hosmer+lemeshow+chi+square+test/pm40180706-74-16-18
Average 90 stars, based on 1 article reviews
hosmer–lemeshow test chi-squared and p value - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results